首页> 外文期刊>Analytical chemistry >Approach for Reliable Evaluation of Drug Proteins Interactions Using Surface Plasmon Resonance Technology
【24h】

Approach for Reliable Evaluation of Drug Proteins Interactions Using Surface Plasmon Resonance Technology

机译:使用表面等离振子共振技术可靠评估药物相互作用的方法

获取原文
获取原文并翻译 | 示例
       

摘要

The surface plasmon resonance (SPR) biosensor was recently introduced to the analytical biochemical society for measuring small drug-protein interactions. However, the technique has many times been used without specifying the type of enantiomeric form of the chiral drug measured and/or with using a too narrow drug concentration range resulting in biased values of binding coefficients and sometimes even assumptions about single-site bindings although the binding in reality comprises a multisite interaction. In this study we will give guidelines for reliable experimental and methodological approaches to avoid these pitfalls. For this purpose, we also introduce a new tool, based on physical chemistry, to the sensor community; the calculation of the adsorption energy distribution (AED). The AED-calculations reveal the degree of heterogeneity directly from the SPR raw data and thus guide us into a narrower selection of probable models before the rival model fitting procedure. We demonstrate how to measure reliable equilibrium data for the two typically different cases: drug binding to (i) transport (plasma) proteins and to (ii) a target protein. Both the binding of the chiral beta-blocker propranolol to (alpha)_(1)-acid glycoprotein (AGP) and that of the anticoagulant warfarin to human serum albumin were heterogeneous, with a few strong enantioselective sites and many weak nonselective sites. We also demonstrate how the multisite binding rapidly falsely turns to single-site as the concentration range is narrowed and how adding dimethyl sulfoxide to the buffer affects multisite drug-protein data. The binding of the enantiomers of the thrombin inhibitor melagatran was investigated on both thrombin and the transport proteins, revealing clear enantioselectivity for thrombin in favor of the active enantiomer, but almost similar binding properties for both enantiomers to the transport protein AGP. The AED-calculations verified that both these system has a unimodal energy distribution and are best described with a homogeneous adsorption model.
机译:表面等离子体共振(SPR)生物传感器最近被引入分析生化学会,用于测量药物-蛋白质之间的小相互作用。然而,该技术已被多次使用,而未指明所测量的手性药物的对映体形式的类型和/或使用的药物浓度范围过窄,导致结合系数的值出现偏差,有时甚至假设单点结合。实际上,绑定包括多站点交互。在这项研究中,我们将为避免这些陷阱的可靠实验和方法论方法提供指导。为此,我们还将基于物理化学的新工具引入传感器社区。吸附能分布(AED)的计算。 AED计算直接从SPR原始数据揭示了异质性程度,因此可以指导我们在竞争对手进行模型拟合之前,先选择较窄的可能模型。我们演示了如何为两种典型的不同情况测量可靠的平衡数据:药物与(i)转运(血浆)蛋白和(ii)目标蛋白的结合。手性β受体阻滞剂普萘洛尔与α_(1)-酸性糖蛋白(AGP)的结合以及抗凝华法林与人血清白蛋白的结合都是异质的,具有几个强的对映选择性位点和许多弱的非选择性位点。我们还证明了随着浓度范围的缩小,多位点结合如何迅速错误地变成单位点,以及向缓冲液中添加二甲亚砜如何影响多位点药物蛋白数据。在凝血酶和转运蛋白上都研究了凝血酶抑制剂美拉加群的对映体的结合,揭示了对凝血酶的明显对映选择性,有利于活性对映体,但两种对映体与转运蛋白AGP的结合特性几乎相似。 AED计算结果证明这两个系统均具有单峰能量分布,并用均质吸附模型进行了最佳描述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号